Advertisement
The SGR fix helps the value-based care evolution

The SGR fix helps the value-based care evolution

By Merrill Goozner  |  March 28, 2015

The incentives in the permanent “doc-fix” legislation, which now has overwhelming bipartisan support from both houses of Congress and the president, will not, by themselves, drive physicians toward value-based compensation schemes.

The spending slowdown is real

The spending slowdown is real

By By  |  March 14, 2015

Over the past two years, conventional wisdom presumed without offering much in the way of evidence that the lingering recession and the rise of high-deductible and narrow network plans explained the slowdown in healthcare spending, now in its fifth year.

The high price of precision medicine

The high price of precision medicine

By By  |  March 07, 2015

Financial markets have sent another signal that the coming era of precision or personalized medicine could wind up making cancer care unaffordable for millions of people.

Round 2: No win for the ACA

Round 2: No win for the ACA

By By  |  February 14, 2015

Forget the smiley face the administration will put on the final numbers from the Affordable Care Act open-enrollment season that just ended. Sign-ups are lagging far behind original projections. And with the political and legal landscape littered with landmines, it's not going to get any easier.

What would Cotton Mather say about the measles vaccine?

What would Cotton Mather say about the measles vaccine?

By By  |  February 07, 2015

Despite the extraordinary gains in public health brought about by vaccinations, there has never been a shortage of people who balk at the scientifically proven method for preventing infectious disease.

Beware vaporware on value-based care

Beware vaporware on value-based care

By By  |  January 31, 2015

The dictionary defines vaporware as a product that has been widely advertised but has not and may never become available. Last week's twin announcements on the imminent move to widespread value-based reimbursement in healthcare bring the concept to mind.

Boosting the right kind of innovation

Boosting the right kind of innovation

By Merrill Goozner  |  January 24, 2015

Nearly two decades ago, Harvard Business School professor Clayton Christensen coined the phrase “disruptive innovation” to describe new technologies that transform industries by bringing simplicity and affordability to products and processes that are complicated and high cost.

Why the FDA should regulate lab tests

Why the FDA should regulate lab tests

By By  |  January 10, 2015

The Food and Drug Administration's proposal to regulate the accuracy of laboratory-developed tests has drawn heated opposition from the laboratory testing industry, hospitals and most medical specialty societies. Only oncologists favor tighter oversight.

Advertisement
Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.